In neuroblastoma, the 27 genes were highly correlated and expressed at much higher levels in patients with advanced disease, with MYCN-amplified tumors, and of older age (>18 months) (Figure 2B), all of which are all predictors of poor outcome [8]. The gene discussed is MYCN; the disease is neuroblastoma.